BACKGROUND The ageing population and the need to support older persons and other vulnerable people in their daily lives have motivated the development of intelligent monitoring systems for assisted environments. OBJECTIVE This study analyses the valorisation pathway of an intelligent monitoring system, addressing three research questions concerning: (1) the social and economic benefits of such technologies, (2) the technical factors enabling their deployment in real settings, and (3) the mechanisms that foster their valorisation. METHODS We combined demographic and policy analysis, user-profile definition, and demand estimation with the design of an Internet-of-Things based architecture, the development of ambient sensors, and preliminary validation in real homes and care facilities. In parallel, a structured review of scientific literature, European projects, patents, and market actors contextualised the proposal within the current assistive-technology ecosystem. RESULTS The combined evidence from the structured review and the proposed architecture indicates that intelligent monitoring systems for assisted environments address a clearly validated societal need, are technically feasible, and face a real market opportunity. An initial valorisation roadmap is outlined, including a university spin-off, business-to-business and business-to-business-to-consumer models, and partnerships with public administrations, service providers and insurers, aligned with the European Care Strategy and the Sustainable Development Goals. Remaining barriers, such as the need for initial investment, regulatory complexity, and the shortage of qualified care personnel, together with the need for Not applicable larger-scale pilots and quality of life impact evaluations, define the agenda for future work. CONCLUSIONS The proposed intelligent monitoring system is technically feasible and addresses a validated societal need. The identified business models and partnerships provide a basis for valorisation, though remaining barriers must be addressed in future work. CLINICALTRIAL Not applicable.